Juan Jesús
Gómez-Reino Carnota
Hospital Universitario Virgen Macarena
Sevilla, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario Virgen Macarena (22)
2019
-
Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept
PLoS ONE, Vol. 14, Núm. 2
-
Factors associated with long-term retention of treatment with golimumab in a real-world setting: an analysis of the Spanish BIOBADASER registry
Rheumatology International, Vol. 39, Núm. 3, pp. 509-515
2018
-
Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial
American Journal of Ophthalmology, Vol. 195, pp. 181-190
-
Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis
PLoS ONE, Vol. 13, Núm. 5
2016
-
Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis
Pharmacogenomics Journal, Vol. 16, Núm. 2, pp. 137-140
2015
-
FCGR polymorphisms in the treatment of rheumatoid arthritis with Fc-containing TNF inhibitors
Pharmacogenomics, Vol. 16, Núm. 4, pp. 333-345
-
Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: A case-only study
Arthritis Research and Therapy, Vol. 17, Núm. 1
2014
-
Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis
Pharmacogenetics and Genomics, Vol. 24, Núm. 5, pp. 238-245
-
Documento práctico para el uso de abatacept subcutáneo
Reumatologia Clinica, Vol. 10, Núm. 4, pp. 218-226
-
Lack of replication of interactions between polymorphisms in rheumatoid arthritis susceptibility: Case-control study
Arthritis Research and Therapy, Vol. 16, Núm. 1
-
Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: A genome-wide association study replication and meta-analysis
Arthritis Research and Therapy, Vol. 16, Núm. 2
2013
-
El uso de abatacept en artritis reumatoide: Revisión de la evidencia y recomendaciones
Reumatologia Clinica, Vol. 9, Núm. 1, pp. 5-17
-
Le facteur rhumatoïde ne semble pas prédire la réponse aux anti-TNF α dans la polyarthrite rhumatoïde: expérience de trois centres
Revue du Rhumatisme (Edition Francaise)
-
Rheumatoid factor does not predict response to TNF antagonists in rheumatoid arthritis: Three centers experience
Joint Bone Spine
2011
-
Safety and retention rate of off-label uses of TNF antagonists in rheumatic conditions: data from the Spanish registry BIOBADASER 2.0
Rheumatology, Vol. 50, Núm. 1, pp. 85-92
2010
-
Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists
Annals of the Rheumatic Diseases, Vol. 69, Núm. 10, pp. 1751-1755
2009
-
Genetic variation in the nuclear factor κB pathway in relation to susceptibility to rheumatoid arthritis
Annals of the Rheumatic Diseases, Vol. 68, Núm. 4, pp. 579-583
-
Lack of association with rheumatoid arthritis of selected polymorphisms in 4 candidate genes: CFH, CD209, Eotaxin-3, and MHC2TA
Journal of Rheumatology, Vol. 36, Núm. 8, pp. 1590-1595
-
Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors
Arthritis and Rheumatism, Vol. 60, Núm. 9, pp. 2558-2564
2008
-
Association of interferon regulatory factor 5 haplotypes, similar to that found in systemic lupus erythematosus, in a large subgroup of patients with rheumatoid arthritis
Arthritis and Rheumatism, Vol. 58, Núm. 5, pp. 1264-1274